Bleeding Disorders
News
FDA approves first tx for rare, deadly clotting disorder
First drug to treat TTP. a rare, lethal blood clotting disorder, has been greenlighted by the FDA.
Feature
Pediatrician with SCD gives her young patients hope
A Nigerian-American hematologist draws on her experience living with sickle cell disease to encourage child patients and advise colleagues.
Feature
Nationwide hematologists shortage: What’s being done?
Efforts are underway to alleviate an acute shortage of U.S. physicians who’ve been trained to treat hemostasis, thrombosis and other blood...
Conference Coverage
Using JAK inhibitors for myelofibrosis
Newer options are improving management of cytopenic patients.
Conference Coverage
CHP/CCUS: Low blood cancer risk for most patients
The goal of ongoing research is to prevent CHIP/CCUS progression in higher-risk patients.
Sponsored Supplement
Best Practices: In the Management of Hemophilia
From the Journals
Hemophilia: Concizumab lessens bleeding, could expand treatment options
The subcutaneous drug concizumab could be an important first treatment for hemophilia B with inhibitors; FDA resubmission is planned.
From the Journals
SCD: Survival disparities seen across insurance types
Nationwide study on sickle cell disease shows life expectancy remains shortened in adulthood, though improved for child patients.
Conference Coverage
SCD, beta-thalassemia: CRISPR-based gene therapy `transformative’
Phase 3 results suggest potential for a “functional cure”; this treatment could become first-ever approved CRISPR gene-editing therapy.
News
FDA approves first gene therapy for hemophilia A
The expensive, one-time, single-dose IV infusion for severe hemophilia A may offer patients years of freedom from infusions.
Latest News
Guide explains nonsurgical management of major hemorrhage
Bleeding affects everybody in medicine, from family doctors in smaller institutions who work in emergency departments to obstetricians and...
From the Journals
Focus of new ASH VTE guidelines: Thrombophilia testing
New guidelines recommend testing for thrombophilia in patients with VTE provoked by a nonsurgical major transient risk factor or associated with...